P&G/Sassoon suit
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble's June 30 motion to dismiss a lawsuit filed by Vidal Sassoon against the firm fails to meet legal standards for the action, Sassoon contends in an Aug. 18 response filed in Los Angeles district court. "Sassoon is under no obligation to prove the claims [against P&G] at this early stage, but only to allege them properly," the document states. Sassoon filed suit in April, claiming P&G, which discontinued the Vidal Sassoon brand in the U.S. in 2002, breached fiduciary duty and implied covenant, in addition to perpetuating actual and constructive fraud in managing the hair care brand. The motion to dismiss is scheduled to be heard by the court Oct. 20 (1"The Rose Sheet" Aug. 11, 2003, p. 5)...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.